))
Ep. 66 - Jane Grogan on Building Biogen’s Growth Engine
Manage episode 433170580 series 3571902
Inhoud geleverd door BioCentury. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door BioCentury of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
As Jane Grogan anticipates the unmet needs in patients five years from now, she’s harnessing a wave of interest in targeting B cells as a key driver of an immunology expansion at Biogen. In conversation with Editor in Chief Simone Fishburn on The BioCentury Show, Grogan, who became EVP and head of research of Biogen in October, discusses how she’s approaching the mission to build diversity and balance the risk in the company’s portfolio, extending further into disease areas beyond neurology.
View full story: https://www.biocentury.com/article/653208
#RandD #DrugDevelopment #neurology #immunology #nephrology #celltherapy #bcells #CD28 #CD38
00:00 - Intro
01:05 – Expanding Research
08:22 – Integrating Hi-Bio
11:30 – Targeting B Cells
16:35 – Growing the Modality Toolbox
Hoofdstukken
1. Ep. 66 - Jane Grogan on Building Biogen’s Growth Engine (00:00:00)
2. Expanding Research (00:01:05)
3. Integrating Hi-Bio (00:08:22)
4. Targeting B Cells (00:11:30)
5. Growing the Modality Toolbox (00:16:35)
17 afleveringen
Delen
